According to GuruFocus Insider Data, these were the largest CEO buys during the past week.
Golub Capital BDC
Golub Capital BDC Inc. (GBDC, Financial) CEO David Golub bought 6,000 shares during the past week at the average price of $13.80.
Golub Capital BDC is an externally managed, closed-end, non-diversified investment management company. The company's investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in U.S. middle-market companies. It also invests in second lien and subordinated loans, warrants and minority equity securities in middle-market companies.
The company has a market cap of $2.34 billion. Its shares traded at $13.96 as of Nov. 27.
Net investment income during the three months ended June 30 was $35.07 million compared to $19.41 million for the prior-year quarter.
CEO David Golub bought 4,488 shares on Nov. 13 at a price of $13.62; 4,000 shares on Nov. 17 at a price of $13.84; 4,000 shares on Nov. 19 at a price of $13.82; 4,000 shares on Nov. 23 at a price of $13.76; and 2,000 shares of GBDC stock on Nov. 24 at a price of $13.88. The price of the stock has increased by 0.58% since then.
Chairman Lawrence E. Golub bought 4,488 shares on Nov. 13 at a price of $13.62; 4,000 shares on Nov. 17 at a price of $13.84; 4,000 shares on Nov. 19 at a price of $13.82; 4,000 shares on Nov. 23 at a price of $13.76; and 2,000 shares on Nov. 24 at a price of $13.88. Since then, the price of the stock has increased by 0.58%.
American Assets Trust
American Assets Trust Inc. (AAT, Financial) Chairman, CEO, President and 10% Owner Ernest S. Rady bought 2,194 shares on Nov. 20 at a price of $28.77. The price of the stock has increased by 4.9% since then.
American Assets Trust is a self-administered real estate investment trust based in the United States. The company invests in, operates and develops retail, office, residential and mixed-use properties primarily located in California, Oregon, Washington and Hawaii.
The company has a market cap of $1.82 billion. Its shares traded at $30.18 with a price-earnings ratio of 47.98 as of Nov. 27.
Net income for the third quarter of 2020 was $5.0 million compared to $12.9 million for the third quarter of 2019.
Rady also bought 175,739 shares on Nov. 4 at a price of $21.64; 130,000 shares on Nov. 6 at a price of $21.49; and 54,994 shares on Nov. 11 at a price of $25.72. Since then, the price of the stock has increased by 17.34%.
Chinook Therapeutics
Chinook Therapeutics Inc. (KDNY, Financial) President and CEO Eric Dobmeier bought 2,000 shares on Nov. 23 at a price of $13.63. The price of the stock has increased by 2.71% since then.
Chinook Therapeutics is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases. The products of the company are focused on rare, severe chronic kidney disorders.
The company has a market cap of $590.22 million. Its shares traded at $14.00 as of Nov. 27.
Net loss for the third quarter of 2020 was $14.54 million compared to a net loss of $20.95 million for the comparable period of 2019.
Dobmeier also bought 4,500 shares on Nov. 11 at a price of $13.8. Since then, the price of the stock has increased by 1.45%.
For the complete list of stocks bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
